Literature DB >> 11675510

Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine.

B Czéh1, T Michaelis, T Watanabe, J Frahm, G de Biurrun, M van Kampen, A Bartolomucci, E Fuchs.   

Abstract

Stress-induced structural remodeling in the adult hippocampus, involving debranching and shortening of dendrites and suppression of neurogenesis, provides a cellular basis for understanding the impairment of neural plasticity in the human hippocampus in depressive illness. Accordingly, reversal of structural remodeling may be a desirable goal for antidepressant therapy. The present study investigated the effect of tianeptine, a modified tricyclic antidepressant, in the chronic psychosocial stress model of adult male tree shrews (Tupaia belangeri), a model with high validity for research on the pathophysiology of major depression. Animals were subjected to a 7-day period of psychosocial stress to elicit stress-induced endocrine and central nervous alterations before the onset of daily oral administration of tianeptine (50 mg/kg). The psychosocial stress continued throughout the treatment period of 28 days. Brain metabolite concentrations were determined in vivo by proton magnetic resonance spectroscopy, cell proliferation in the dentate gyrus was quantified by using BrdUrd immunohistochemistry, and hippocampal volume was measured post mortem. Chronic psychosocial stress significantly decreased in vivo concentrations of N-acetyl-aspartate (-13%), creatine and phosphocreatine (-15%), and choline-containing compounds (-13%). The proliferation rate of the granule precursor cells in the dentate gyrus was reduced (-33%). These stress effects were prevented by the simultaneous administration of tianeptine yielding normal values. In stressed animals treated with tianeptine, hippocampal volume increased above the small decrease produced by stress alone. These findings provide a cellular and neurochemical basis for evaluating antidepressant treatments with regard to possible reversal of structural changes in brain that have been reported in depressive disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11675510      PMCID: PMC60133          DOI: 10.1073/pnas.211427898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

Review 1.  The corticosteroid receptor hypothesis of depression.

Authors:  F Holsboer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

2.  Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy.

Authors:  R J Steingard; D A Yurgelun-Todd; J Hennen; J C Moore; C M Moore; K Vakili; A D Young; A Katic; W R Beardslee; P F Renshaw
Journal:  Biol Psychiatry       Date:  2000-12-01       Impact factor: 13.382

Review 3.  The cellular neurobiology of depression.

Authors:  H K Manji; W C Drevets; D S Charney
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

Review 4.  Tianeptine: a review of its use in depressive disorders.

Authors:  A J Wagstaff; D Ormrod; C M Spencer
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro.

Authors:  H Manev; T Uz; N R Smalheiser; R Manev
Journal:  Eur J Pharmacol       Date:  2001-01-05       Impact factor: 4.432

6.  Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus.

Authors:  J L Trejo; E Carro; I Torres-Aleman
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

7.  Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells.

Authors:  G Rajkowska
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

8.  Effects of adverse experiences for brain structure and function.

Authors:  B S McEwen
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

9.  Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.

Authors:  J E Malberg; A J Eisch; E J Nestler; R S Duman
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

10.  NMDA receptor antagonist treatment induces a long-lasting increase in the number of proliferating cells, PSA-NCAM-immunoreactive granule neurons and radial glia in the adult rat dentate gyrus.

Authors:  J Nacher; D R Rosell; G Alonso-Llosa; B S McEwen
Journal:  Eur J Neurosci       Date:  2001-02       Impact factor: 3.386

View more
  254 in total

1.  Depression, antidepressants, and the shrinking hippocampus.

Authors:  R M Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

2.  Re-evaluation and in silico annotation of the Tupaia herpesvirus proteins.

Authors:  Udo Bahr; Gholamreza Darai
Journal:  Virus Genes       Date:  2004-01       Impact factor: 2.332

Review 3.  Stress and plasticity in the limbic system.

Authors:  Robert M Sapolsky
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

4.  Stress coping stimulates hippocampal neurogenesis in adult monkeys.

Authors:  David M Lyons; Paul S Buckmaster; Alex G Lee; Christine Wu; Rupshi Mitra; Lauren M Duffey; Christine L Buckmaster; Song Her; Paresh D Patel; Alan F Schatzberg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-30       Impact factor: 11.205

Review 5.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

Review 6.  Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: unraveling the genome to understand the mind.

Authors:  Jenny Hsieh; Amelia J Eisch
Journal:  Neurobiol Dis       Date:  2010-01-28       Impact factor: 5.996

7.  Treatment with tianeptine induces antidepressive-like effects and alters the neurotrophin levels, mitochondrial respiratory chain and cycle Krebs enzymes in the brain of maternally deprived adult rats.

Authors:  Franciela P Della; Helena M Abelaira; Gislaine Z Réus; Maria Augusta B dos Santos; Débora B Tomaz; Altamir R Antunes; Giselli Scaini; Meline O S Morais; Emilio L Streck; João Quevedo
Journal:  Metab Brain Dis       Date:  2013-01-18       Impact factor: 3.584

8.  Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder.

Authors:  Eric Vermetten; Meena Vythilingam; Steven M Southwick; Dennis S Charney; J Douglas Bremner
Journal:  Biol Psychiatry       Date:  2003-10-01       Impact factor: 13.382

Review 9.  Stress and brain atrophy.

Authors:  J Douglas Bremner
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-10       Impact factor: 4.388

Review 10.  Neuroimaging in posttraumatic stress disorder and other stress-related disorders.

Authors:  J Douglas Bremner
Journal:  Neuroimaging Clin N Am       Date:  2007-11       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.